FONAR Corporation
NASDAQ:FONRMedical - Devices
+$0.00 today
- Market cap
- $117.76M
- Beta
- 0.95
- P/E (TTM)
- 17.6
- EPS (TTM)
- $1.08
Volume 0.00M
Average 0.08M
FONR Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
FONAR CorporationNASDAQ: FONR
Property, Plant & Equipment (Net) · Q3 FY2026 · quarter ended Mar 2026
Property, plant & equipment (net) falls 3.4% from a year ago
Property, plant & equipment (net) stood at $53.42M at the end of Q3 FY2026, down 3.4% from a year earlier and down 3.2% from the prior quarter. Over 3 fiscal years it compounded at -2.0% a year.
Context
- Property, plant & equipment (net) amounted to 24.4% of total assets at the end of Q3 FY2026, down 1.4 pp from a year earlier.
- Property, plant & equipment (net) increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether property, plant & equipment (net) keeps falling in the next quarterly balance sheet after a -3.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Property, Plant & Equipment (Net) history
USD · from the balance sheet
- Latest · FY2025
- 54.04M USD
- Year-over-year change
- -6.3%
- 4-year CAGR
- +0.4%
| Period | Period end | Property, Plant & Equipment (Net) | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 54.04M | -6.3% |
| FY2024 | 2024-06-30 | 57.67M | +3.1% |
| FY2023 | 2023-06-30 | 55.94M | -2.6% |
| FY2022 | 2022-06-30 | 57.44M | +8.2% |
| FY2021 | 2021-06-30 | 53.11M | — |
Property, Plant & Equipment (Net) vs competitors
How FONR compares with its peers on the latest reported figures
- Peers report in different currencies, so property, plant & equipment (net) is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -3.4% is the 5th highest of 8, against a peer median of -3.2%.
- Property, plant & equipment (net) amounts to 24.4% of total assets for FONR, versus a peer median of 16.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $56.03M USD | +1711.0% | -7.8% | 92.9% | |
| Mar 2026 | $53.42M USD | -3.4% | -2.0% | 24.4% | |
| Mar 2026 | $19.71M USD | -8.3% | +24.5% | 16.4% | |
| Mar 2026 | $19.37M USD | +1.2% | +117.3% | 45.7% | |
ARTVArtiva Biotherapeutics, Inc. | Mar 2026 | $16.3M USD | -21.6% | -14.3% | 15.4% |
| Mar 2026 | $10.88M USD | -17.9% | +77.8% | 21.1% | |
| Mar 2026 | $6.33M USD | -3.2% | -4.5% | 10.0% | |
| Mar 2026 | €1.07M EUR | +18.3% | -11.2% | 2.2% | |
| Peer median (excluding FONR) | — | -3.2% | -4.5% | 16.4% | |
Competitors are the stored peer set for FONR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 44.46M | 48.72M | 51.28M | 56.34M | 56.33M |
| Short-term Investments | 32.18K | 32.33K | 32.8K | 136.1K | 120.49K |
| Net Receivables | 61.2M | 66.47M | 70.17M | 79.85M | 82.94M |
| Inventory | 1.66M | 2.36M | 2.57M | 2.72M | 2.81M |
| Other Current Assets | 0 | 0 | 0 | 1.29M | 2.46M |
| Total Current Assets | 108.58M | 118.69M | 125.66M | 140.32M | 144.67M |
| Property, Plant & Equipment (Net) | 53.11M | 57.44M | 55.94M | 57.67M | 54.04M |
| Goodwill | 4.27M | 4.27M | 4.27M | 4.27M | 4.27M |
| Intangible Assets | 4.04M | 3.7M | 3.43M | 2.87M | 2.99M |
| Long-term Investments | 0 | 1.87M | 710.09K | 0 | 0 |
| Tax Assets | 15.96M | 12.84M | 10.04M | 7.22M | 6.35M |
| Other Non-current Assets | 3.55M | 526.27K | 523.51K | 1.89M | 4.58M |
| Total Non-current Assets | 80.92M | 80.66M | 74.92M | 73.92M | 72.24M |
| Total Assets | 189.51M | 199.34M | 200.58M | 214.25M | 216.91M |
| Account Payables | 1.87M | 1.55M | 1.58M | 1.86M | 1.3M |
| Short-term Debt | 173.21K | 40.08K | 43.77K | 47K | 0 |
| Tax Payables | 1.42M | 630.7K | 241.39K | 1.66M | 640.32K |
| Deferred Revenue | 5.11M | 4.65M | 4.43M | 4.31M | 5.22M |
| Other Current Liabilities | 943.24K | 1.07M | 785.75K | 1.6M | 1.89M |
| Total Current Liabilities | 20.05M | 16.75M | 15.62M | 17.86M | 17.12M |
| Long-term Debt | 760.25K | 155.38K | 115.08K | 66.94K | 0 |
| Deferred Tax Liabilities | 238.32K | 215.73K | 394.76K | 371.56K | 321.16K |
| Deferred Revenue (Non-current) | 2.8M | 1.86M | 760.24K | 1.17M | 3.8M |
| Other Non-current Liabilities | 263.99K | 199.2K | 134.41K | 124.69K | 265.52K |
| Total Non-current Liabilities | 34.09M | 36.36M | 34.13M | 39.6M | 39.68M |
| Total Liabilities | 54.14M | 53.11M | 49.75M | 57.46M | 56.8M |
| Common Stock | 695 | 695 | 685 | 673 | 660 |
| Retained Earnings | (46.01M) | (33.57M) | (24.19M) | (13.62M) | (5.29M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | (3.05M) | (4.05M) | (7.08M) | (9.18M) | (12.5M) |
| Total Equity | 135.37M | 146.24M | 150.83M | 156.79M | 160.1M |
| Total Debt | 34.69M | 38.22M | 37.01M | 41.68M | 38.92M |
| Net Debt | (9.77M) | (10.51M) | (14.27M) | (14.67M) | (17.42M) |
FONAR Corporation
NASDAQ:FONR
Intrinsic Alpha fair value
Locked
Current Price
$19.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.